PMC:7195088 / 25324-25616 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T124","span":{"begin":16,"end":25},"obj":"Disease"},{"id":"T125","span":{"begin":119,"end":127},"obj":"Disease"},{"id":"T126","span":{"begin":170,"end":178},"obj":"Disease"}],"attributes":[{"id":"A124","pred":"mondo_id","subj":"T124","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A125","pred":"mondo_id","subj":"T125","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A126","pred":"mondo_id","subj":"T126","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Umifenovir Anti-influenza membrane fusion inhibitor • In a recent RCT published on a preprint server and comparing 120 COVID-19 patients treated with favipiravir vs. 120 COVID-19 patients receiving umifenovir, higher rates of clinical recovery were observed in patients receiving favipiravir."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T125","span":{"begin":26,"end":34},"obj":"http://purl.obolibrary.org/obo/UBERON_0000158"},{"id":"T126","span":{"begin":57,"end":58},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T127","span":{"begin":83,"end":84},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Umifenovir Anti-influenza membrane fusion inhibitor • In a recent RCT published on a preprint server and comparing 120 COVID-19 patients treated with favipiravir vs. 120 COVID-19 patients receiving umifenovir, higher rates of clinical recovery were observed in patients receiving favipiravir."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T343","span":{"begin":42,"end":51},"obj":"Chemical"},{"id":"T344","span":{"begin":150,"end":161},"obj":"Chemical"},{"id":"T345","span":{"begin":198,"end":208},"obj":"Chemical"},{"id":"T346","span":{"begin":280,"end":291},"obj":"Chemical"}],"attributes":[{"id":"A343","pred":"chebi_id","subj":"T343","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A344","pred":"chebi_id","subj":"T344","obj":"http://purl.obolibrary.org/obo/CHEBI_134722"},{"id":"A345","pred":"chebi_id","subj":"T345","obj":"http://purl.obolibrary.org/obo/CHEBI_134730"},{"id":"A346","pred":"chebi_id","subj":"T346","obj":"http://purl.obolibrary.org/obo/CHEBI_134722"}],"text":"Umifenovir Anti-influenza membrane fusion inhibitor • In a recent RCT published on a preprint server and comparing 120 COVID-19 patients treated with favipiravir vs. 120 COVID-19 patients receiving umifenovir, higher rates of clinical recovery were observed in patients receiving favipiravir."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T6","span":{"begin":26,"end":41},"obj":"http://purl.obolibrary.org/obo/GO_0061025"}],"text":"Umifenovir Anti-influenza membrane fusion inhibitor • In a recent RCT published on a preprint server and comparing 120 COVID-19 patients treated with favipiravir vs. 120 COVID-19 patients receiving umifenovir, higher rates of clinical recovery were observed in patients receiving favipiravir."}

{"project":"LitCovid-sentences","denotations":[{"id":"T189","span":{"begin":0,"end":292},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Umifenovir Anti-influenza membrane fusion inhibitor • In a recent RCT published on a preprint server and comparing 120 COVID-19 patients treated with favipiravir vs. 120 COVID-19 patients receiving umifenovir, higher rates of clinical recovery were observed in patients receiving favipiravir."}